Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nipocalimab in adults with warm autoimmune hemolytic anemia
MOH_2019-09-02_007380Phase 3Recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nipocalimab in warm autoimmune hemolytic anemia (wAIHA) (3 arms), sponsored by Janssen Pharmaceutical. Started Jul 2019; status: recruiting.
02
Drugs
nipocalimab
03
Conditions
warm autoimmune hemolytic anemia (wAIHA)
Beyond the preview
Go deeper on MOH_2019-09-02_007380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-09-02_007380.